-
Switching from salvage chemotherapy to immunotherapy in adult B-cell acute lymphoblastic leukemia
Author: Kegyes, David; Jitaru, Ciprian; Ghiaur, Gabriel; Ciurea, Stefan; Hoelzer, Dieter; Tomuleasa, Ciprian; Gale, Robert Peter
Journal: BLOOD REVIEWS. 2023; Vol. 59, Issue , pp. -. DOI: 10.1016/j.blre.2023.101042
-
Radiation and leukaemia: Which leukaemias and what doses?
Author: Gale, Robert Peter
Journal: BLOOD REVIEWS. 2023; Vol. 58, Issue , pp. -. DOI: 10.1016/j.blre.2022.101017
-
A promising sword of tomorrow: Human γδ T cell strategies reconcile allo-HSCT complications.
Author: Hu Y, Cui Q, Luo C, Luo Y, Shi J, Huang H.
Journal: Blood Rev. 2016 May;30(3):179-88. doi: 10.1016/j.blre.2015.11.002. Epub 2015 Nov 25. Review.
-
Swallowing a bitter pill-oral arsenic trioxide for acute promyelocytic leukemia.
Author: Torka P, Al Ustwani O, Wetzler M, Wang ES, Griffiths EA.
Journal: Blood Rev. 2016 May;30(3):201-11. doi: 10.1016/j.blre.2015.11.004. Epub 2015 Dec 3. Review.
-
Autophagy as a target for hematological malignancy therapy.
Author: Dong Z, Liang S, Hu J, Jin W, Zhan Q, Zhao K.
Journal: Blood Rev. 2016 Apr 16. pii: S0268-960X(16)30013-3. doi: 10.1016/j.blre.2016.04.005. [Epub ahead of print] Review.
-
Autophagy as a target for hematological malignancy therapy
Author: Kewen Zhao
Journal: Blood Reviews, 2016.
-
Autophagy as a target for hematological malignancy therapy
Author: Zhiwu Dong
Journal: Blood Reviews, 2016.
-
Autophagy as a target for hematological malignancy therapy
Author: Zhiwu Dong, Shuang Liang, Jun Hu, Weiyun Jin, Qilin Zhan, Kewen Zhao
Journal: BLOOD REVIEWS, 2016, Vol.30, 369-380, DOI:10.1016/j.blre.2016.04.005